State bills · Health
What's moving in state legislatures -- introductions, committee action, floor votes and sponsors.
Filter bills
-
PS 1406 — Puerto Rico
“Para enmendar la Ley 72-1993, según enmendada, mejor conocida como “Ley de la Administración de Seguros de Salud de Puerto Rico”, a los fines de consolidar la operación y administración de la Oficina del Programa de Medicaid de Puerto Rico, adscrita al Departamento de Salud, con la Administración de Seguros de Salud (ASES), designando la última como la Agencia Estatal Única (Single State Agency) para los fines de la Sección 1902 de la Ley de Seguridad Social federal (Social Security Act); para
-
BDR 54-463 — Nevada
Revises provisions governing pharmacists.
-
BDR 57-464 — Nevada
Revises provisions relating to pharmacists.
-
HB 385 — Delaware
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO GRANTS FOR NURSE PRECEPTORS.
While the exact number of nurse vacancies in Delaware fluctuates, healthcare providers agree that the current shortage is unsustainable. Nursing shortages lead to missed nursing care, higher morbidity, and mortality rates. The American Association of Colleges of Nursing (AACN) outlines a number of contributing factors impacting the current national nursing shortage. One is a lack of nursing school faculty - including the preceptors that provide supervision and instruction for clinical practice. Since Delaware’s nursing education programs must require clinical learning experiences provided by these preceptors, nursing students have difficulty completing the required coursework necessary for degree and licensure. Section 1 of this Act provides for an annual appropriation in an amount determined by the General Assembly to the Delaware Nursing Workforce Initiative or similar nonprofit to administer a program to provide funding to hospitals and clinical facilities to implement or continue offering preceptorship programs. Section 2 provides that this Act is effective 6 months after enactment.
-
SB 878 — Missouri
Modifies provisions relating to pharmaceutical drugs and devices
HCS/SS/SCS/SB 878 - This act modifies provisions relating to pharmaceutical drugs and devices. LIMITS ON SALE OF OVER-THE-COUNTER DRUGS (SECTIONS 195.417 & 579.060) Currently, no person shall sell, dispense, or purchase, over a 12 month period, more than a total amount of 43.2 grams of certain meth precursors. This act increases the amount to 61.2 grams. Beginning October 1, 2026, any manufacturer of a meth precursor drug that is sold in or into this state shall pay a monthly fee to the administrator of the real-time electronic pseudoephedrine tracking system, as described in the act. The fee is set by the administrator. A manufacturer commits the offense of unlawful, sale, distribution, or purchase of over-the-counter methamphetamine precursor drugs if the manufacturer knowingly fails to pay the fees required by this act. These provisions are identical to provisions in SS/SCS/SB 841 (2026), in the truly agreed to and finally passed CCS/SS/SB 1421 (2026), HCS/HB 1962 (2026), in SCS/HB 2146 (2026), in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026) and are substantially similar to provisions in SB 1069 (2026), SB 726 (2025), HB 1036 (2025), provisions of HCS/SS/SB 7 (2025), SCS/SB 317 (2025), SCS/HCS/HB 943 (2025), SB 548 (2025), and SB 143 (2025). PRACTICE OF PHARMACY - VACCINES (SECTION 338.010) Currently, the practice of pharmacy includes the ordering and administration of vaccines approved or authorized by the FDA, but excludes certain vaccines and those vaccines approved after January 1, 2023. This act instead provides that the practice of pharmacy includes the ordering and administration of certain vaccines approved or authorized by the FDA as of January 1, 2026, but excludes certain vaccines and those vaccines approved by the FDA after January 1, 2026, that are not included by joint rules promulgated by the Board of Pharmacy and the State Board of Registration for the Healing Arts. This provision is identical to a provision in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), is substantially similar to a provision in the truly agreed to and finally passed HCS/SS#2/SB 1233 (2026), and is similar to a provision in SS/SCS/SB 841 (2026), HB 1976 (2026), and in SCS/HCS/HB 3009 (2026). MEDICATION THERAPEUTIC PLAN AUTHORITY (SECTION 338.012) Currently, a pharmacist with a certificate of medication therapeutic plan authority can provide certain medication therapy services if there is a statewide order issued by the Director or the Chief Medical Officer of the Department of Health and Senior Services if such person is a licensed physician or by a licensed physician designated by the Department. This act repeals this language and authorizes the provision of such medication therapy services pursuant to rules established by the Board of Pharmacy and the State Board of Registration for the Healing Arts. This provision is identical to a provision in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), in SCS/HB 2591 (2026), and in SCS/HCS/HB 3009 (2026), and is similar to a provision in HB 3499 (2026). MEDICAL DEVICE PRESCRIPTIONS (SECTION 338.206) This act authorizes pharmacists to prescribe medical devices, as defined in the act. The Board of Pharmacy and the State Board of Registration for the Healing Arts shall jointly promulgate rules to implement this provision within six months of the effective date of this act. This provision is identical to a provision in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026) and is substantially similar to a provision in SCS/HB 2591 (2026), in SCS/HCS/HB 3009 (2026), and in HB 3499 (2026). DISPENSING OF IVERMECTIN & HYDROXYCHLOROQUINE (SECTION 338.208) Under this act, a pharmacist may dispense ivermectin and hydroxychloroquine to a person, without a prescription order, upon the approval of a warning label for the use and indication in accordance with any written, standardized procedures or protocols issued by the Board of Pharmacy. Any ivermectin or hydroxychloroquine that is dispensed by a pharmacist or by a pharmacy technician under a pharmacist's supervision without a prescription shall be kept behind the counter or otherwise not available in a self-service area and be stored in a secure area accessible only to pharmacy personnel. This provision is identical to a provision in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026) and is similar to a provision in SCS/HCS/HB 3009 (2026). PHARMACY EMERGENCY WAIVERS (SECTION 338.312) The Board of Pharmacy shall have the authority to waive compliance with any Missouri rule or regulation for pharmacies dispensing, shipping, or delivering prescription drugs into another state or United States territory that is experiencing a declared state disaster or emergency, provided that: (1) The pharmacy is a licensed pharmacy in good standing and is authorized to ship prescription drugs into such state or territory; (2) The pharmacy is responding to a declared state disaster or emergency; (3) The pharmacy complies with all emergency rules and regulations for pharmacies established by the state or territory for the duration of the disaster period; (4) The pharmacy complies with all applicable federal laws and regulations; and (5) The waiver applies only to prescription drugs dispensed, shipped, or delivered to residents or health care facilities located within the geographic area specified in the declared state disaster or emergency. This provision is identical to a provision in the truly agreed to and finally passed HCS/SS#2/SB 1233 (2026), in HCS/HB 2300 (2026), in SCS/HCS/HB 2372 (2026), and in SCS/HB 3009 (2026), and is similar to provision in SB 1640 (2026). 340B DRUGS (SECTION 376.417) Under this act, a health carrier, a pharmacy benefits manager, or an agent or affiliate of such, shall not discriminate against a covered entity, as defined in the act, including by reimbursing the covered entity for a quantity of a 340B drug in an amount less than it would pay similarly situated non-covered entities for such drugs, imposing different terms and conditions as compared to similarly situated entities, refusing to cover 340B drugs or discriminating in reimbursement for 340B drugs, and other situations described under this act. The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier, pharmacy benefits manager, or agent or affiliate of such, that violates this provision, not to exceed $5,000 per violation per day. This provision is identical to a provision in SS/SCS/SB 841 (2026), in HCS/SB 1019 (2026), SB 1340 (2026), in SCS/HB 2146 (2026), in the truly agreed to and finally passed SCS/HCS/HB 2372 (2026), in SCS/HCS/HB 943 (2025), and HB 784 (2025). COVERAGE OF NONOPIOID PRESCRIPTION DRUGS (SECTION 376.1280) This provides that health benefit plans shall not deny coverage of a nonopioid prescription drug in favor of an opioid drug, require the enrollee to try an opioid drug before covering the nonopioid drug, or require a higher level of cost-sharing for a nonopioid prescription drug than for an opioid drug. This act shall apply to health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027. This provision is identical to a provision in SS/SCS/SB 841 (2026) and is similar to SB 902 (2026), a provision in HCS/SB 1019 (2026), SB 1350 (2026), SB 1449 (2026), HB 1680 (2026), HB 1966 (2026), HB 2296 (2026), in SCS/HCS/HB 2372 (2026), HCS/HB 2642 (2026), SB 158 (2025), HB 804 (2025), and provisions in HCS/SS/SB 7 (2025). COVERAGE OF HOME BLOOD PRESSURE MONITORING DEVICES (SECTION 376.1960) This act provides that health benefit plans providing for maternity benefits shall provide coverage for a home blood pressure monitoring device and home blood pressure monitoring device services, as defined in the act, for pregnant and postpartum women when determined to be medically appropriate in accordance with American College of Obstetricians and Gynecologists guidelines. This act shall apply to health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027. This provision is identical to a provision in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026) and is similar to SB 1089 (2026), a provision in HCS/HB 2371 (2026), in SB 539 (2025), and in HB 842 (2025). KATIE O'BRIEN
-
HB 1798 — New Hampshire
relative to the coverage of diapers under the state Medicaid plan.
-
HB 1653 — New Hampshire
relative to emergency medical care provided at freestanding hospital emergency facilities.
-
HB 1337 — New Hampshire
repealing the New Hampshire council on autism spectrum disorders.
-
HB 1067 — New Hampshire
relative to the mental health courts.
-
HB 1572 — New Hampshire
relative to licensure as a master licensed alcohol and drug counselor.
-
SB 501 — New Hampshire
relative to authorization of seclusion or restraint during a personal safety emergency by a physician, physician associate, or advanced practice registered nurse.
-
HB 1616 — New Hampshire
prohibiting state agencies and political subdivisions from advertising or expending funds to advertise vaccines in the state of New Hampshire.
-
HB 232 — New Hampshire
relative to the rights of conscience for medical professionals.
-
AB 1929 — California
Health care coverage: investments: disclosure.
Existing federal law, the Patient Protection and Affordable Care Act (PPACA) , requires each state to establish an American Health Benefit Exchange to facilitate the purchase of qualified health benefit plans by qualified individuals and qualified small employers. Existing state law creates the California Health Benefit Exchange, also known as Covered California, to facilitate the enrollment of qualified individuals and qualified small employers in qualified health plans offered by participating carriers as required under PPACA. This bill would require a nonprofit health care service plan participating in the Exchange to annually disclose its material investment holdings to the Exchange on or before July 1 of each year, unless otherwise specified by regulation, beginning on July 1, 2027. The bill would require the Exchange to prominently display, and make accessible to the public, those disclosures on its internet website. If a plan fails to comply with the disclosure requirements, the bill would require the Department of Managed Health Care to assess an administrative penalty against the plan, as specified. The bill would require the Exchange to prominently post the plan's noncompliance status on its internet website until compliance is achieved.
-
SCR 7 — California
Relative to permanent standard time.
This measure would proclaim that the Legislature acknowledges the health benefits of permanent standard time.
-
HB 2734 — Pennsylvania
An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
-
RC 747 — Puerto Rico
Para ordenar a la Comisión de Gobierno de la Cámara de Representantes del Estado Libre Asociado de Puerto Rico realizar una investigación exhaustiva sobre la determinación del Departamento de Salud de no renovar el contrato de servicios de vigilancia de la empresa Genesis Security Services, Inc. en el Hospital Universitario Ramón Ruiz Arnau, con el propósito de otorgarlo a otras compañías; indagar sobre los criterios económicos y operacionales que justifican esta decisión cuando la propuesta de
-
AB 65 — California
School and community college employees: paid disability and parental leave.
Existing law requires the governing board of a school district, and the governing board of a community college district, to provide for a leave of absence from duty for a certificated employee or an academic employee of the district who is required to be absent from duty because of pregnancy, miscarriage, childbirth, and recovery from those conditions. Existing law authorizes the governing board of a school district, and the governing board of a community college district, to provide for a leave of absence from duty as it deems appropriate for a female employee in the classified service of the district who is required to be absent from duty because of pregnancy or convalescence following childbirth. Existing law authorizes a governing board to adopt rules and regulations about leaves of absence for classified employees for these purposes, and authorizes a governing board to provide in the rules and regulations whether the leave granted shall be with or without pay, as provided. This bill would delete the latter provisions authorizing a governing board of a school district and the governing board of a community college district to adopt those rules and regulations. The bill instead would require a public school employer to, for a certificated employee or an employee in the classified service of the public school employer, and would require a community college district to, for an academic employee or an employee in the classified service of the community college district, provide up to 14 weeks of a leave of absence with specified pay benefits for an employee who is required to be absent from duty because of pregnancy, miscarriage, childbirth, termination of pregnancy, or recovery from those conditions, as provided. The bill would authorize the paid leave to begin before and continue after childbirth if the employee is actually disabled by pregnancy, childbirth, termination of pregnancy, or a related condition. The bill would prohibit a leave of absence taken pursuant to these provisions from being deducted from other leaves of absence, as provided, and would require public school employers and community college districts to maintain group health coverage for an employee who takes a leave of absence under these provisions for the duration of the leave of absence at the same level and under the same conditions that coverage would have been provided if the employee had not taken a leave of absence. The bill would prohibit any other eligibility requirements, including, but not limited to, minimum hours worked or length of service, before an employee disabled by pregnancy, childbirth, termination of pregnancy, or related medical conditions is eligible for a paid leave of absence under these provisions.
-
RS 151 — Puerto Rico
Para ordenar a la Comisión de Salud del Senado de Puerto Rico realizar una investigación exhaustiva sobre la efectividad del Departamento de Salud en la mitigación y manejo de la crisis de opioides; evaluar las iniciativas, estrategias, uso de fondos asignados, y coordinación interagencial desarrollada para enfrentar dicha crisis; y para otros fines relacionados.
-
SB 255 — Delaware
AN ACT TO AMEND TITLE 21 OF THE DELAWARE CODE RELATING TO TINTING OF MOTOR VEHICLE WINDSHIELD, WINDOWS, OR SIDE WINGS.
Currently, window tint or other material placed on the front side windows of a motor vehicle must have a visible light transmission of 70% or greater unless the vehicle’s owner has a statement signed by a licensed practitioner of medicine and surgery or osteopathic medicine or optometry verifying that tinted windows are medically necessary. Currently, there is not a visible light transmission requirement for the side windows behind the driver or the rear window. This Act is a substitute for Senate Bill No. 255. Like Senate Bill No. 255, this Act does all of the following: (1) Changes the visible light transmission requirement for window tint or other material placed on the front side windows. (2) Clarifies that there is not a visible light transmission requirement for the side windows behind the driver or the rear window. (3) Clarifies the exception for vehicles operated by a law-enforcement officer by exempting these vehicles from this law. This Act differs from Senate Bill No. 255 by changing the visible requirement for window tint or other material placed on the front side windows, and side wings, from 35% or great to 50% or greater.
-
PC 1062 — Puerto Rico
Para declarar y reconocer a la Sociedad Pro Hospital del Niño, conocida comúnmente como “Hospital del Niño”, Patrimonio del Pueblo puertorriqueño, en reconocimiento a su trayectoria de más de cien (100) años brindando servicios médicos, terapéuticos, educativos dirigidos a atender condiciones crónicas o severas de la niñez en Puerto Rico.
-
B 26-0751 — District of Columbia
Health and Human Service Programs and Benefits Eligibility and Delivery Data-Sharing Clarifications Emergency Amendment Act of 2026
-
HR 132 — California
Relative to Young Women's Reproductive Health Awareness Month.
-
AB 1925 — California
State permanent disability certification program: feasibility study.
Existing law establishes various programs for the delivery of services or benefits to individuals with disabilities, including, among others, the State Supplementary Program for the Aged, Blind, and Disabled, regional center services and supports under the Lanterman Developmental Disabilities Services Act, the In-Home Supportive Services Program, and certain benefits within the Medi-Cal program. This bill would require the California Health and Human Services Agency, upon appropriation and in consultation with relevant state departments within the agency, to complete a feasibility study that includes a comprehensive analysis of the challenges and opportunities related to establishing a state permanent disability certification program. Under the bill, the program would be defined as a certification issued by a state department confirming that an individual has a permanent disability for the purpose of obtaining services. The bill would require the agency to reasonably attempt to consult with local stakeholders, as specified. The bill would require that the analysis within the study address, among other things, technological limitations and compatibility of a permanent disability certification for use within existing federal, state, and local programs. The bill would require the agency, by July 1, 2028, to submit a report of the completed study to the Legislature and to post the report on the agency's internet website. The bill would repeal these provisions on January 1, 2032.
-
AB 1851 — California
Pupil health: social-emotional, behavioral, and mental health supports.
Existing law requires the governing board of a school district to give diligent care to the health and physical development of pupils and authorizes the governing board of a school district to employ properly certified persons for this purpose. Existing law requires a school of a school district or county office of education and a charter school to notify pupils and parents or guardians of pupils no less than twice during the school year on how to initiate access to available pupil mental health services on campus or in the community, or both, as provided. This bill would require, on or before July 1, 2027, the State Department of Education to enter into a contract with one or more local educational agencies with capacity and established expertise, as provided, to serve as lead entities in providing support for the implementation of integrated, universal social-emotional learning, behavioral health, and restorative practices for pupils in kindergarten and grades 1 to 12, inclusive. The bill would require, on or before January 1, 2028, the lead entities, selected pursuant to a competitive process, to make available guidance, resources, and technical assistance to local educational agencies to expand the statewide implementation of integrated, universal social-emotional learning, behavioral health, and restorative practices, as provided. The bill would make the implementation of these provisions contingent upon an appropriation, as provided.
-
AB 308 — California
Developmental services: safety training.
Existing law, the Lanterman Developmental Disabilities Services Act, requires the State Department of Developmental Services to contract with regional centers for the provision of services and supports for persons with developmental disabilities and their families. Existing law, until July 1, 2026, creates the Advisory Council on Improving Interactions between People with Intellectual and Development Disabilities and Law Enforcement, under the Department of Justice, to, among other things, evaluate existing training for peace officers specific to interactions between law enforcement and individuals with intellectual and developmental disabilities. Existing law requires the council to submit a report including recommendations to the Legislature for improving outcomes of interactions with both individuals who have an intellectual or developmental disability and mental health conditions, as specified. This bill would require the State Department of Developmental Services to conduct a statewide evaluation of safety training services provided by regional centers, as specified. The bill would require the department, by July 1, 2028, to submit a report to the Legislature summarizing its findings and recommendations and would require the recommendations to address specified topics, including, among others, recommendations for establishing standardized, statewide protocols for responding to crises involving individuals with intellectual or developmental disabilities. The bill would state the intent of the Legislature to consider, upon receipt and consideration of that report, providing funding to the department for the purpose of developing, implementing, and sustaining safety training services statewide.
-
AB 1990 — California
Pharmacy Law: advertising certain compounded medications used for obesity or weight management.
Existing law, the Pharmacy Law, requires the California State Board of Pharmacy within the Department of Consumer Affairs to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. Under existing law, it is unlawful for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription unless they are licensed, as specified. Existing law also requires the compounding of drug preparations by a pharmacy for furnishing, distribution, or use to be consistent with standards established in the pharmacy compounding chapters of the current version of the United States Pharmacopeia-National Formulary, including relevant testing and quality assurance. Existing law authorizes advertisements for prescription drugs, if the advertisement conforms with certain requirements, including not containing a false, fraudulent, misleading, or deceptive statement. A violation of the Pharmacy Law is a crime. This bill would make it unlawful for any person to advertise or otherwise promote certain compounded medications used for obesity or weight management, as provided, unless the advertisement is truthful and not misleading, including not containing an unsubstantiated claim with respect to the product. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
-
HB 5691 — West Virginia
Supplemental appropriation, Department of Health
-
AB 2141 — California
Pharmacies: license discipline: stipulated settlement and disciplinary order.
Under existing state law, the Pharmacy Law, the California State Board of Pharmacy licenses and regulates the practice of pharmacy in this state. Existing law sets forth various disciplinary actions, including license suspension or revocation, against licensees for offenses committed under those licensing provisions. Existing law requires discipline proceedings to be conducted in accordance with the administrative adjudicative provisions of the Administrative Procedure Act (APA) . Existing law authorizes an agency to formulate and issue a decision by settlement, as provided, except in an adjudicative proceeding to determine whether an occupational license should be revoked, suspended, limited, or conditioned, existing law prohibits a settlement from being made before issuance of the agency pleading. This bill would authorize the board and licensee to enter into a stipulated settlement and disciplinary order to license discipline without and in advance of the filing of an agency pleading, notwithstanding the above-referenced requirement concerning the APA, and if prescribed conditions are met, including, among others, that the licensee willingly waives the administrative adjudicative procedures of the APA and the licensee submitted mitigation and rehabilitation information, as provided. The bill would require a specified committee of the board to consider the mitigation and rehabilitation information and authorize the committee to extend a stipulated settlement and discipline order offer to the licensee, as provided. The bill would require that the stipulated settlement and disciplinary order be agreed to in writing between the committee and the licensee within 60 calendar days of the date of the licensee's waiver of the administrative adjudicative procedures of the APA, as provided. The bill would provide that the stipulated settlement and disciplinary order is contingent upon approval by the board, as provided.